Our Services
We deliver end‑to‑end life‑sciences innovation services spanning discovery, pre‑clinical development, clinical research, and commercialization, integrating deep expertise in biologics, vaccines, diagnostics, and advanced therapeutics with cutting‑edge computational biology, multi‑omics, and AI/ML‑driven analytics; our capabilities include target and biomarker discovery, protein science, assay and bioanalytical development, pre‑clinical and IND‑enabling support, CRAMS and central laboratory services, Phase I–IV clinical development and trial management, regulatory and global submission support, and downstream commercialization readiness, all executed through robust digital, modeling, and advanced computing platforms and delivered under stringent GMP, GLP, GCP, and GCLP quality and regulatory frameworks to accelerate translation from concept to clinic and market.
Antibodies II Bispecifics II Fusion Proteins II Recombinant Proteins II Protein Therapeutics
Discovery & Translational Research
Biologics and biomarker discovery, verification, and validation
Protein science, enzyme kinetics, binding affinity and speficity
Assay development and analytical method validation
Bioinformatics, systems biology, genomics, proteomics, and multi‑omics platforms
AI/ML powered simulation, discovery and development platform
Discovery to IND enabling and precision medicine strategies.
Clinical Development & Trial Management
Phase I–IV clinical trial support
Study design and protocol development
Site management, monitoring, and quality assurance
Clinical and translational laboratory services
Data management and clinical analytics
Bioavailability, bioequivalence, and pharmacokinetic studies
Regulatory affairs and global submission support (IND, NDA, BLA, CTA, etc.)
Quality & Compliance
Integrated Pre‑Clinical Research & Development
Disease biology and mechanism‑of‑action studies
Biochemical and immunological characterization
Bioanalytical assay development
Analytical method development and validation
Potency, binding, and functional assays
Immunogenicity assay
Pre‑Clinical Bioanalytics
Pre‑IND and IND‑enabling study support
Genomics, proteomics, and multi‑omics analysis
AI/ML‑enabled data analysis for pre‑clinical decision making
Contract Research & Manufacturing Services
Central laboratory and bioanalytical services
Biologics, vaccines, monoclonal antibodies, recombinant proteins, and biosimilars
Cell and gene therapy support
Product and process development
Formulation, delivery systems, and stability studies
Immunogenicity testing and comparability studies
Sample management and cold‑chain logistics
Formulation & Development Support
GMP, GLP, GCP, and GCLP‑compliant operations
Our Work
Discovery Phase
Our innovative platform provide deep insight on drug-target affinity and kinetics and removes development risk early on
Clinical Support
Our team guides clinical trials design and plan with data-driven AI/ML powered insights, ensuring reduction of molecular level risks in translation from lab discoveries to patient-ready therapies.
Pre-Clinical Phase
We dive deep into protein science, disease biology, using innovative platform and AI and machine learning to uncover new biologic targets and accelerate early-stage research with precision and speed.
Contract Research & Manufacturing Services
Expert Team Solving the Toughest Biologic Development and Manufacturing Challenges
Bridging science and innovation seamlessly
At Proteo Quant, better biologics decisions start with deeper molecular insight
Biologics programs with data of micro-second level affinity and functional readouts
Proteo Quant helps uncover what standard screening misses:
mechanistic binding behavior
transient interaction kinetics
early developability liabilities
molecular stability risks
candidate comparability differences
Kinetic Intelligence: Data Beyond Kd
kon
koff
residence time
transient binding phases
mechanistic binding models
Developability Intelligence: Early risk assessment across
aggregation
self-interaction
thermal stability
colloidal stability
Analytical Characterization: Build molecular confidence through
purity assessment
heterogeneity analysis
stability characterization
comparability profiling
Get in Touch
Reach out to bionexis for tailored support on your biologics and vaccine projects.
P
+1-555-789-4321
E
contact@bionexis.com
